I am a
Home I AM A Search Login

Papers of the Week

Papers: 23 Mar 2024 - 29 Mar 2024

Am J Ther




Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine.


Evans VD, Arenas A, Shinozuka K, Tabaac BJ, Beutler BD, Cherian K, Fasano C, Muir OS


Ketamine, an arylcyclohexylamine dissociative anesthetic agent, has evolved into a versatile therapeutic. It has a rapid-onset, well-understood cardiovascular effects and a favorable safety profile in clinical use. Its enantiomeric compound, esketamine, was approved by the Food and Drug Administration in 2019 for both treatment-resistant depression and major depressive disorder with suicidal ideation.